AU2022271388A1 - Heteroaryl derivative compounds, and uses thereof - Google Patents
Heteroaryl derivative compounds, and uses thereof Download PDFInfo
- Publication number
- AU2022271388A1 AU2022271388A1 AU2022271388A AU2022271388A AU2022271388A1 AU 2022271388 A1 AU2022271388 A1 AU 2022271388A1 AU 2022271388 A AU2022271388 A AU 2022271388A AU 2022271388 A AU2022271388 A AU 2022271388A AU 2022271388 A1 AU2022271388 A1 AU 2022271388A1
- Authority
- AU
- Australia
- Prior art keywords
- pyrimidin
- amine
- phenyl
- 6alkyl
- isoxazolidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20210063733 | 2021-05-17 | ||
| KR10-2021-0063733 | 2021-05-17 | ||
| PCT/KR2022/006994 WO2022245085A1 (ko) | 2021-05-17 | 2022-05-16 | 헤테로아릴 유도체 화합물 및 이의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022271388A1 true AU2022271388A1 (en) | 2022-12-01 |
Family
ID=84141801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022271388A Pending AU2022271388A1 (en) | 2021-05-17 | 2022-05-16 | Heteroaryl derivative compounds, and uses thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US12037330B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4342895A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7896880B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102607051B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115667251A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022271388A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022024068A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3180295A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL298474A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022014887A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI869674B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022245085A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12037346B2 (en) | 2021-04-13 | 2024-07-16 | Nuvalent, Inc. | Amino-substituted heteroaryls for treating cancers with EGFR mutations |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115667251A (zh) * | 2021-05-17 | 2023-01-31 | 株式会社沃若诺伊生物 | 杂芳基衍生物化合物、及其用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL161662A0 (en) | 2001-11-01 | 2004-09-27 | Janssen Pharmaceutica Nv | Heteroaryl amines as glycogen synthase kinase 3 beta inhibitors (gsk3 inhibitors) |
| GB0215844D0 (en) | 2002-07-09 | 2002-08-14 | Novartis Ag | Organic compounds |
| GB0512324D0 (en) | 2005-06-16 | 2005-07-27 | Novartis Ag | Organic compounds |
| TWI389893B (zh) | 2007-07-06 | 2013-03-21 | Astellas Pharma Inc | 二(芳胺基)芳基化合物 |
| KR101247840B1 (ko) | 2008-02-22 | 2013-03-26 | 에프. 호프만-라 로슈 아게 | 아밀로이드 베타 조절제 |
| EP3205650B1 (en) | 2014-10-11 | 2021-08-04 | Shanghai Hansoh Biomedical Co., Ltd. | Egfr inhibitor, and preparation and application thereof |
| EP3929190B1 (en) | 2014-10-13 | 2024-12-25 | Yuhan Corporation | Compounds and compositions for modulating egfr mutant kinase activities |
| JP2020526499A (ja) | 2017-07-05 | 2020-08-31 | シーエス ファーマテック リミテッド | Egfrチロシンキナーゼの臨床上重要な突然変異体の選択的阻害剤 |
| US11440899B2 (en) | 2017-10-17 | 2022-09-13 | Merck Patent Gmbh | Pyrimidine TBK/IKKe inhibitor compounds and uses thereof |
| JP7109013B2 (ja) | 2019-03-19 | 2022-07-29 | ボロノイ インコーポレイテッド | ヘテロアリール誘導体、ヘテロアリール誘導体の生成方法、およびヘテロアリール誘導体を有効成分として含む医薬組成物 |
| WO2020235902A1 (ko) * | 2019-05-17 | 2020-11-26 | 주식회사 보로노이 | 헤테로고리 융합 피리미딘 유도체 및 이의 용도 |
| KR20210032093A (ko) | 2019-09-16 | 2021-03-24 | 제이투에이치바이오텍 (주) | Egfr 돌연변이 키나제 성장 억제 효과를 나타내는 피리미딘 유도체 및 이의 의약 용도 |
| US20230322753A1 (en) | 2020-09-18 | 2023-10-12 | Voronoi Inc. | Heteroaryl derivative, method for preparation thereof, and pharmaceutical composition comprising same as active ingredient |
| KR20220085735A (ko) | 2020-12-14 | 2022-06-22 | 보로노이바이오 주식회사 | 아이소옥사졸리딘 유도체 화합물 및 이의 용도 |
| US20240262815A1 (en) | 2021-05-07 | 2024-08-08 | Voronoi Inc. | Heteroaryl derivative, method for preparing same, and pharmaceutical composition comprising same as active ingredient |
| CN115667251A (zh) * | 2021-05-17 | 2023-01-31 | 株式会社沃若诺伊生物 | 杂芳基衍生物化合物、及其用途 |
-
2022
- 2022-05-16 CN CN202280004578.7A patent/CN115667251A/zh active Pending
- 2022-05-16 CA CA3180295A patent/CA3180295A1/en active Pending
- 2022-05-16 BR BR112022024068A patent/BR112022024068A2/pt unknown
- 2022-05-16 JP JP2022573567A patent/JP7896880B2/ja active Active
- 2022-05-16 AU AU2022271388A patent/AU2022271388A1/en active Pending
- 2022-05-16 WO PCT/KR2022/006994 patent/WO2022245085A1/ko not_active Ceased
- 2022-05-16 EP EP22793620.0A patent/EP4342895A4/en active Pending
- 2022-05-16 KR KR1020220059638A patent/KR102607051B1/ko active Active
- 2022-05-16 MX MX2022014887A patent/MX2022014887A/es unknown
- 2022-05-16 IL IL298474A patent/IL298474A/en unknown
- 2022-05-16 US US17/927,324 patent/US12037330B2/en active Active
- 2022-05-17 TW TW111118417A patent/TWI869674B/zh active
-
2023
- 2023-11-22 KR KR1020230163623A patent/KR20230163335A/ko active Pending
-
2024
- 2024-01-16 US US18/414,371 patent/US12528799B2/en active Active
- 2024-06-01 US US18/731,285 patent/US12534457B2/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12037346B2 (en) | 2021-04-13 | 2024-07-16 | Nuvalent, Inc. | Amino-substituted heteroaryls for treating cancers with EGFR mutations |
Also Published As
| Publication number | Publication date |
|---|---|
| US20240317730A1 (en) | 2024-09-26 |
| US12534457B2 (en) | 2026-01-27 |
| TWI869674B (zh) | 2025-01-11 |
| TW202310845A (zh) | 2023-03-16 |
| US20240166640A1 (en) | 2024-05-23 |
| IL298474A (en) | 2023-01-01 |
| CN115667251A (zh) | 2023-01-31 |
| US20240025888A1 (en) | 2024-01-25 |
| US12037330B2 (en) | 2024-07-16 |
| KR20220156453A (ko) | 2022-11-25 |
| JP7896880B2 (ja) | 2026-07-29 |
| EP4342895A4 (en) | 2025-09-10 |
| CA3180295A1 (en) | 2022-11-24 |
| BR112022024068A2 (pt) | 2023-12-05 |
| EP4342895A1 (en) | 2024-03-27 |
| KR20230163335A (ko) | 2023-11-30 |
| KR102607051B1 (ko) | 2023-11-30 |
| US12528799B2 (en) | 2026-01-20 |
| WO2022245085A1 (ko) | 2022-11-24 |
| JP2024519626A (ja) | 2024-05-21 |
| MX2022014887A (es) | 2023-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112778276B (zh) | 作为shp2抑制剂的化合物及其应用 | |
| CN112574235B (zh) | 一种ret抑制剂、其药物组合物及其用途 | |
| CN112939967B (zh) | 吡唑并[1,5-a]吡啶类化合物及其制备方法和应用 | |
| CN113135910A (zh) | 嘧啶-4(3h)-酮类杂环化合物、其制备方法及其在医药学上的应用 | |
| WO2020181283A1 (en) | Carboxamide-pyrimidine derivatives as shp2 antagonists | |
| IL277518B2 (en) | Substituted imidazolidin-2-one derivatives as prmt5 inhibitors | |
| JP7663968B2 (ja) | Wdr5阻害剤及び調節剤 | |
| CA3108676A1 (en) | Carboxamides as ubiquitin-specific protease inhibitors | |
| CA3145348A1 (en) | Pyrazolone and pyrimidine compound, and preparation method and use therefor | |
| US12534457B2 (en) | Heteroaryl derivative compounds, and uses thereof | |
| KR20220090443A (ko) | 헤테로아릴 유도체 화합물 및 이의 용도 | |
| KR20240041340A (ko) | 피롤로피리미딘 유도체 화합물 및 이의 용도 | |
| KR20220097305A (ko) | 헤테로아릴 유도체 화합물 및 이의 용도 | |
| WO2025253326A1 (ko) | Kras 저해제로서 신규한 3환 화합물 및 이의 용도 | |
| AU2023250757A1 (en) | Heteroaryl derivative and use thereof | |
| KR20230153951A (ko) | 헤테로아릴 유도체 화합물 및 이의 용도 | |
| EA052736B1 (ru) | Гетероарильные производные и их применение | |
| HK40108597A (en) | Heteroaryl derivative compound and use thereof | |
| RU2831125C1 (ru) | Класс конденсированных кольцевых соединений и их получение и применение | |
| HK40087825A (en) | Heteroaryl derivative compound and use thereof | |
| US20250368635A1 (en) | Heteroaryl derivative compound, and uses thereof | |
| CA3269132A1 (en) | Heteroaryl derivative compound, and uses thereof | |
| WO2023187471A1 (en) | Heteroaryl derivative compounds, and uses thereof | |
| KR20240133663A (ko) | 헤테로아릴 유도체 및 이의 용도 | |
| KR20240104016A (ko) | 헤테로아릴 유도체 화합물 및 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: VORONOI INC. Free format text: FORMER APPLICANT(S): VORONOI INC.; VORONOIBIO INC. |